semaglutide studies for weight loss Two-year effects of in adults with overweight or obesity: the STEP 5 trial Semaglutide Shines as Weight Loss

Recent preclinical studies (Matalka et al., 2024) showed that GHK-Cu reduces the accumulation of beta-amyloid protein and phosphorylated tau protein in cellular models of Alzheimer's disease

Research is ongoing, though

Both glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter-2 (SGLT-2) inhibitors can reduce CV risk in patients with T2D, and both are recommended by the American Diabetes Association to reduce the risk of major cardiovascular events (MACE)

Understand your insurance's prior authorization process before you need it

This approach aims to help more people reach clinically meaningful loss without surgery

GIP (Glucose-Dependent Insulinotropic Polypeptide) A hormone that enhances insulin secretion and may affect fat metabolism